Global mean potassium intake: a systematic review and Bayesian meta-analysis.


Journal

European journal of nutrition
ISSN: 1436-6215
Titre abrégé: Eur J Nutr
Pays: Germany
ID NLM: 100888704

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 29 12 2022
accepted: 20 02 2023
medline: 17 7 2023
pubmed: 8 3 2023
entrez: 7 3 2023
Statut: ppublish

Résumé

Increasing potassium intake, especially in populations with low potassium intake and high sodium intake, has emerged as an important population-level intervention to reduce cardiovascular events. Current guideline recommendations, such as those made by the World Health Organisation, recommend a potassium intake of  > 3.5 g/day. We sought to determine summary estimates for mean potassium intake and sodium/potassium (Na/K) ratio in different regions of the world. We performed a systematic review and meta-analysis. We identified 104 studies, that included 98 nationally representative surveys and 6 multi-national studies. To account for missingness and incomparability of data, a Bayesian hierarchical imputation model was applied to estimating summary estimates of mean dietary potassium intake (primary outcome) and sodium/potassium ratio. Overall, 104 studies from 52 countries were included (n = 1,640,664). Mean global potassium intake was 2.25 g/day (57 mmol/day) (95% credible interval (CI) 2.05-2.44 g/day), with highest intakes in Eastern and Western Europe (mean intake 3.53g/day, 95% CI 3.05-4.01 g/day and 3.29 g/day, 95% CI 3.13-3.47 g/day, respectively) and lowest intakes in East Asia (mean intake 1.89 g/day; 95% CI 1.55-2.25 g/day). Approximately 31% (95% CI, 30-41%) of global population included have an estimated potassium intake  > 2.5 g/day, with 14% (95% CI 11-17%) above 3.5 g/day. Global mean potassium intake (2.25 g/day) falls below current guideline recommended intake level of  > 3.5 g/day, with only 14% (95% CI 11-17%) of the global population achieving guideline-target mean intake. There was considerable regional variation, with lowest mean potassium intake reported in Asia, and highest intake in Eastern and Western Europe.

Identifiants

pubmed: 36882596
doi: 10.1007/s00394-023-03128-6
pii: 10.1007/s00394-023-03128-6
pmc: PMC10349712
doi:

Substances chimiques

Potassium RWP5GA015D
Potassium, Dietary 0
Sodium 9NEZ333N27
Sodium, Dietary 0

Types de publication

Systematic Review Meta-Analysis Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2027-2037

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 203930/B/16/Z
Pays : United Kingdom

Informations de copyright

© 2023. The Author(s).

Références

Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
Arch Intern Med. 2009 Jan 12;169(1):32-40
pubmed: 19139321
Asia Pac J Clin Nutr. 2013;22(4):490-504
pubmed: 24231008
Am J Clin Nutr. 2006 Jun;83(6):1289-96
pubmed: 16762939
Lancet. 2016 Dec 10;388(10062):e19-e23
pubmed: 27371184
BMJ Open. 2013 Dec 23;3(12):e003733
pubmed: 24366578
Circulation. 2017 May 9;135(19):1775-1783
pubmed: 28483828
BMJ. 1988 Jul 30;297(6644):319-28
pubmed: 3416162
N Engl J Med. 2014 Aug 14;371(7):601-11
pubmed: 25119606
Am J Clin Nutr. 1984 Oct;40(4):786-93
pubmed: 6486085
BMJ. 1997 Sep 20;315(7110):722-9
pubmed: 9314758
N Engl J Med. 2022 Jan 20;386(3):252-263
pubmed: 34767706
BMJ. 2019 Mar 13;364:l772
pubmed: 30867146
BMJ. 2013 Apr 03;346:f1378
pubmed: 23558164
Stat Methods Med Res. 1996 Dec;5(4):339-55
pubmed: 9004377
Lancet Glob Health. 2020 Jan;8(1):e59-e66
pubmed: 31708415
N Engl J Med. 2001 Jan 4;344(1):3-10
pubmed: 11136953
N Engl J Med. 2021 Sep 16;385(12):1067-1077
pubmed: 34459569
Lancet. 2012 Dec 15;380(9859):2063-6
pubmed: 23245602
Syst Rev. 2016 Dec 5;5(1):210
pubmed: 27919275
BMJ Open. 2015 Mar 20;5(3):e006625
pubmed: 25795689
Am J Clin Nutr. 2012 Sep;96(3):647-57
pubmed: 22854410
Eur Heart J. 2022 Sep 14;43(35):3365-3367
pubmed: 35923132
JAMA. 2011 Nov 23;306(20):2229-38
pubmed: 22110105
Arch Intern Med. 2010 Sep 13;170(16):1501-2
pubmed: 20837839

Auteurs

Catriona Reddin (C)

HRB-Clinical Research Facility, National University of Ireland Galway, Galway University Hospital, Newcastle Road, Galway, H91YR71, Ireland. reddin.catriona@gmail.com.
Wellcome Trust-HRB, Irish Clinical Academic Training, Galway, Ireland. reddin.catriona@gmail.com.

John Ferguson (J)

HRB-Clinical Research Facility, National University of Ireland Galway, Galway University Hospital, Newcastle Road, Galway, H91YR71, Ireland.

Robert Murphy (R)

HRB-Clinical Research Facility, National University of Ireland Galway, Galway University Hospital, Newcastle Road, Galway, H91YR71, Ireland.

Aoibhin Clarke (A)

HRB-Clinical Research Facility, National University of Ireland Galway, Galway University Hospital, Newcastle Road, Galway, H91YR71, Ireland.

Conor Judge (C)

HRB-Clinical Research Facility, National University of Ireland Galway, Galway University Hospital, Newcastle Road, Galway, H91YR71, Ireland.
Wellcome Trust-HRB, Irish Clinical Academic Training, Galway, Ireland.

Vincent Griffith (V)

HRB-Clinical Research Facility, National University of Ireland Galway, Galway University Hospital, Newcastle Road, Galway, H91YR71, Ireland.

Alberto Alvarez (A)

HRB-Clinical Research Facility, National University of Ireland Galway, Galway University Hospital, Newcastle Road, Galway, H91YR71, Ireland.

Andrew Smyth (A)

HRB-Clinical Research Facility, National University of Ireland Galway, Galway University Hospital, Newcastle Road, Galway, H91YR71, Ireland.

Andrew Mente (A)

Population Health Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada.

Salim Yusuf (S)

Population Health Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada.

Martin J O'Donnell (MJ)

HRB-Clinical Research Facility, National University of Ireland Galway, Galway University Hospital, Newcastle Road, Galway, H91YR71, Ireland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH